ロード中...

Evaluating drug-free remission with abatacept in early rheumatoid arthritis: results from the phase 3b, multicentre, randomised, active-controlled AVERT study of 24 months, with a 12-month, double-blind treatment period

OBJECTIVES: To evaluate clinical remission with subcutaneous abatacept plus methotrexate (MTX) and abatacept monotherapy at 12 months in patients with early rheumatoid arthritis (RA), and maintenance of remission following the rapid withdrawal of all RA treatment. METHODS: In the Assessing Very Earl...

詳細記述

保存先:
書誌詳細
出版年:Ann Rheum Dis
主要な著者: Emery, Paul, Burmester, Gerd R, Bykerk, Vivian P, Combe, Bernard G, Furst, Daniel E, Barré, Emilie, Karyekar, Chetan S, Wong, Dennis A, Huizinga, Tom W J
フォーマット: Artigo
言語:Inglês
出版事項: BMJ Publishing Group 2015
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4283672/
https://ncbi.nlm.nih.gov/pubmed/25367713
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/annrheumdis-2014-206106
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!